{
  "id": 16762767,
  "title": "Gubra looks beyond metabolism, hopes for first portfolio company this year",
  "url": "https://urgent.news/2026/10/27/gubra-looks-beyond-metabolism-hopes-for-first-portfolio-company-this",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-27T15:21:31.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/gubra-looks-beyond-metabolism-hopes-for-first-portfolio-company-this-year/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The Copenhagen-based drugmaker Gubra's present is mostly about obesity. Its future will need to be about a much broader pipeline. The company has a portfolio of weight loss drug candidates but is moving into the ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}